PEDIATRICS Vol. 98 No. 5 November 1996, pp. 1003-1004
This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Demers, R. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Demers, R. R.

Letter To The Editor

Robert R. Demers RRT1

1 Demers Consulting Services Carmel CA, 93923

The AAP statement entitled "Reassessment of the Indications for Ribavirin Therapy in Respiratory Syncytial Virus Infections" by the Committee on Infectious Diseases1 recently published in this journal was noted with interest. It is extremely unfortunate that the Committee placed so little credence in the Stanford study published in the New England Journal of Medicine in 1991,2 while placing excessive confidence in the fatally flawed Wayne State study published in Critical Care Medicine in 1994.3 The Stanford study, among others, was criticized because ". . . the choice of water as a placebo . . . could have biased the results in favor of ribavirin efficacy."1